JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB1890

Anti-Lyn 抗体 [LYN-01]

Anti-Lyn antibody [LYN-01]

3

(6 Reviews)

|

(22 Publications)

Mouse Monoclonal LYN antibody. Suitable for Flow Cyt, WB and reacts with Human, Rat, Recombinant full length protein - Human samples. Cited in 22 publications. Immunogen corresponding to Recombinant Fragment Protein within Human LYN aa 1-250.

別名を表示する

JTK8, Tyrosine-protein kinase Lyn, Lck/Yes-related novel protein tyrosine kinase, V-yes-1 Yamaguchi sarcoma viral related oncogene homolog, p53Lyn, p56Lyn

4 Images
Flow Cytometry - Anti-Lyn antibody [LYN-01] (AB1890)
  • Flow Cyt

Unknown

Flow Cytometry - Anti-Lyn antibody [LYN-01] (AB1890)

Overlay histogram showing Ramos (Human Burkitt's lymphoma cell line) cells stained with ab1890 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab1890, 1μg/1x106 cells) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-mouse IgG (H+L) (ab96879) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was mouse IgG1 [ICIGG1] (ab91353, 2μg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed. This antibody gave a positive signal in Ramos cells fixed with 4% paraformaldehyde (10 min)/permeabilized with 0.1% PBS-Tween for 20 min used under the same conditions.

Western blot - Anti-Lyn antibody [LYN-01] (AB1890)
  • WB

Supplier Data

Western blot - Anti-Lyn antibody [LYN-01] (AB1890)

Non reducing conditions with 60 minutes exposure time in a 12% gel

All lanes:

Western blot - Anti-Lyn antibody [LYN-01] (ab1890) at 1 µg/mL

Lane 1:

Negative control

Lane 2:

Rat basophilic leukemia cell line

Lane 3:

JURKAT human peripheral blood T cell leukemia cell line

Lane 4:

A-431 human epidermoid carcinoma cell line

Lane 5:

U-937 human histiocytic lymphoma cell line

Predicted band size: 59 kDa

false

Western blot - Anti-Lyn antibody [LYN-01] (AB1890)
  • WB

AbReview20797****

Western blot - Anti-Lyn antibody [LYN-01] (AB1890)

All lanes:

Western blot - Anti-Lyn antibody [LYN-01] (ab1890) at 1/1000 dilution

All lanes:

HEK-293 (Human epithelial cell line from embryonic kidney) whole cell lysate at 50 µg

Secondary

All lanes:

HRP-conjugated anti-mouse at 1/10000 dilution

Predicted band size: 59 kDa

Observed band size: 56 kDa

false

Image courtesy of an anonymous Abreview.

Western blot - Anti-Lyn antibody [LYN-01] (AB1890)
  • WB

Unknown

Western blot - Anti-Lyn antibody [LYN-01] (AB1890)

All lanes:

Western blot - Anti-Lyn antibody [LYN-01] (ab1890) at 1/1000 dilution

All lanes:

Recombinant human Lyn protein (ab60306) at 0.01 µg

Secondary

All lanes:

Western blot - Goat Anti-Mouse IgG H&L (HRP) preadsorbed (<a href='/products/secondary-antibodies/goat-mouse-igg-h-l-hrp-preadsorbed-ab97040'>ab97040</a>) at 1/3000 dilution

Predicted band size: 59 kDa

true

Exposure time: 4min

Key facts

宿主種

Mouse

クローン性

Monoclonal

クローン番号

LYN-01

アイソタイプ

IgG1

キャリアフリー

No

交差種

Rat, Human

アプリケーション

Flow Cyt, WB

applications

免疫原

Recombinant Fragment Protein within Human LYN aa 1-250. The exact immunogen used to generate this antibody is proprietary information.

P07948

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "FlowCyt-species-checked": "testedAndGuaranteed", "FlowCyt-species-dilution-info": "1 µg for 10^6 Cells", "FlowCyt-species-notes": "<p><a href='/products/primary-antibodies/mouse-igg1-kappa-monoclonal-15-6e10a7-isotype-control-ab170190'>ab170190</a> - Mouse monoclonal IgG1, is suitable for use as an isotype control with this antibody.</p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1-2 µg/mL", "WB-species-notes": "<p></p>" }, "Rat": { "FlowCyt-species-checked": "guaranteed", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1-2 µg/mL", "WB-species-notes": "<p></p>" }, "Recombinant full length protein - Human": { "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1-2 µg/mL", "WB-species-notes": "<p></p>" } } }

製品の詳細

Lyn is a member of the src family of non-receptor protein tyrosine kinases that is predominantly expressed in haematopoietic tissues. Like all members of the src family, lyn is thought to participate in signal transduction from cell surface receptors that lack intrinsic tyrosine kinase activity. It is associated with a number of cell surface receptors including the B cell antigen receptor and immunoglobulin E receptor (FceRI).

出荷温度及び保存条件

製品の状態
Liquid
精製方法
Affinity purification Protein A
精製に関する特記事項
Purified from hybridoma culture supernatant. Purity >95% by SDS-PAGE.
バッファー組成
pH: 7.4 Preservative: 0.097% Sodium azide Constituents: PBS
出荷温度
Blue Ice
短期保存期間
1-2 weeks
短期保存温度
+4°C
長期保存温度
-20°C
分注に関する情報
Upon delivery aliquot
保管に関する情報
Avoid freeze / thaw cycle

補足情報

This supplementary information is collated from multiple sources and compiled automatically.

Lyn kinase also known as p56 or Lyn protein is a member of the Src family of protein tyrosine kinases. It possesses a molecular weight of approximately 56 kDa. Lyn is mainly expressed in hematopoietic cells such as B-lymphocytes mast cells and myeloid cells. It plays a critical role in the signaling pathways involving these cells. Lyn is located on the inner surface of the plasma membrane and requires lipid modification for membrane association. Additionally it is present in neuronal tissues and other non-immune cell types reflecting a broader role in cellular signal transduction.
Biological function summary

As a regulator in signal transduction Lyn kinase is involved in the formation of protein complexes that modulate cell activation and proliferation. It participates in the phosphorylation of downstream substrates which leads to the initiation of various cellular responses. Lyn modulates pathways involving inflammation and immune responses impacting the development and function of immune cells. It is important for balancing activation and inhibition signals in the immune system ensuring a controlled immune response.

Pathways

Lyn kinase interacts with the B-cell receptor (BCR) signaling pathway and the Fc epsilon RI signaling pathway in mast cells. It associates with other Src family kinases like Fyn and Lck to regulate BCR signaling which influences B-cell development and differentiation. Lyn also acts upstream of pathways that control the release of inflammatory mediators. Through its role in these pathways Lyn indirectly impacts downstream processes and affects cellular communication and immune system homeostasis.

Lyn dysfunction has implications for conditions like chronic myeloid leukemia and systemic lupus erythematosus. Abnormal Lyn activity alters signal transduction leading to unregulated cell proliferation and immune dysregulation. In chronic myeloid leukemia Lyn interacts with the BCR/ABL fusion protein contributing to the malignant transformation of hematopoietic cells. In systemic lupus erythematosus Lyn regulates signaling pathways that prevent autoimmunity; imbalances can lead to an excessive immune response. These connections highlight Lyn's importance in both cell regulation and its involvement in pathological states.

製品プロトコール

For this product, it's our understanding that no specific protocols are required. You can visit:

ターゲットの情報

Non-receptor tyrosine-protein kinase that transmits signals from cell surface receptors and plays an important role in the regulation of innate and adaptive immune responses, hematopoiesis, responses to growth factors and cytokines, integrin signaling, but also responses to DNA damage and genotoxic agents. Functions primarily as negative regulator, but can also function as activator, depending on the context. Required for the initiation of the B-cell response, but also for its down-regulation and termination. Plays an important role in the regulation of B-cell differentiation, proliferation, survival and apoptosis, and is important for immune self-tolerance. Acts downstream of several immune receptors, including the B-cell receptor, CD79A, CD79B, CD5, CD19, CD22, FCER1, FCGR2, FCGR1A, TLR2 and TLR4. Plays a role in the inflammatory response to bacterial lipopolysaccharide. Mediates the responses to cytokines and growth factors in hematopoietic progenitors, platelets, erythrocytes, and in mature myeloid cells, such as dendritic cells, neutrophils and eosinophils. Acts downstream of EPOR, KIT, MPL, the chemokine receptor CXCR4, as well as the receptors for IL3, IL5 and CSF2. Plays an important role in integrin signaling. Regulates cell proliferation, survival, differentiation, migration, adhesion, degranulation, and cytokine release. Involved in the regulation of endothelial activation, neutrophil adhesion and transendothelial migration (PubMed : 36932076). Down-regulates signaling pathways by phosphorylation of immunoreceptor tyrosine-based inhibitory motifs (ITIM), that then serve as binding sites for phosphatases, such as PTPN6/SHP-1, PTPN11/SHP-2 and INPP5D/SHIP-1, that modulate signaling by dephosphorylation of kinases and their substrates. Phosphorylates LIME1 in response to CD22 activation. Phosphorylates BTK, CBL, CD5, CD19, CD72, CD79A, CD79B, CSF2RB, DOK1, HCLS1, LILRB3/PIR-B, MS4A2/FCER1B, SYK and TEC. Promotes phosphorylation of SIRPA, PTPN6/SHP-1, PTPN11/SHP-2 and INPP5D/SHIP-1. Mediates phosphorylation of the BCR-ABL fusion protein. Required for rapid phosphorylation of FER in response to FCER1 activation. Mediates KIT phosphorylation. Acts as an effector of EPOR (erythropoietin receptor) in controlling KIT expression and may play a role in erythroid differentiation during the switch between proliferation and maturation. Depending on the context, activates or inhibits several signaling cascades. Regulates phosphatidylinositol 3-kinase activity and AKT1 activation. Regulates activation of the MAP kinase signaling cascade, including activation of MAP2K1/MEK1, MAPK1/ERK2, MAPK3/ERK1, MAPK8/JNK1 and MAPK9/JNK2. Mediates activation of STAT5A and/or STAT5B. Phosphorylates LPXN on 'Tyr-72'. Kinase activity facilitates TLR4-TLR6 heterodimerization and signal initiation. Phosphorylates SCIMP on 'Tyr-107'; this enhances binding of SCIMP to TLR4, promoting the phosphorylation of TLR4, and a selective cytokine response to lipopolysaccharide in macrophages (By similarity). Phosphorylates CLNK (By similarity). Phosphorylates BCAR1/CAS and NEDD9/HEF1 (PubMed : 9020138).
See full target information LYN

文献 (22)

Recent publications for all applications. Explore the full list and refine your search

Disease models & mechanisms 17: PubMed38149669

2024

Conditional in vivo deletion of LYN kinase has little effect on a BRCA1 loss-of-function-associated mammary tumour model.

Applications

Unspecified application

Species

Unspecified reactive species

Giusy Tornillo,Lauren Warrington,Howard Kendrick,Adam T Higgins,Trevor Hay,Sam Beck,Matthew J Smalley

Science advances 8:eabj5227 PubMed35452291

2022

A dominant function of LynB kinase in preventing autoimmunity.

Applications

Unspecified application

Species

Unspecified reactive species

Ben F Brian,Monica L Sauer,Joseph T Greene,S Erandika Senevirathne,Anders J Lindstedt,Olivia L Funk,Brian L Ruis,Luis A Ramirez,Jennifer L Auger,Whitney L Swanson,Myra G Nunez,Branden S Moriarity,Clifford A Lowell,Bryce A Binstadt,Tanya S Freedman

Current oncology (Toronto, Ont.) 29:1939-1946 PubMed35323358

2022

Novel, First-in-Human, Oral PCLX-001 Treatment in a Patient with Relapsed Diffuse Large B-Cell Lymphoma.

Applications

Unspecified application

Species

Unspecified reactive species

Randeep Sangha,Neal M Davies,Afshin Namdar,Michael Chu,Jennifer Spratlin,Erwan Beauchamp,Luc G Berthiaume,John R Mackey

Frontiers in molecular neuroscience 14:688050 PubMed34630032

2021

Tandem Mass Tag-Based Quantitative Proteomic Analysis Reveals Pathways Involved in Brain Injury Induced by Chest Exposure to Shock Waves.

Applications

Unspecified application

Species

Unspecified reactive species

Changci Tong,Peifang Cong,Ying Liu,Xiuyun Shi,Lin Shi,Shun Mao,Yan Zhao,Mingxiao Hou,Yunen Liu

Frontiers in cell and developmental biology 9:662763 PubMed34485271

2021

NLGN3 Upregulates Expression of ADAM10 to Promote the Cleavage of NLGN3 Activating the LYN Pathway in Human Gliomas.

Applications

Unspecified application

Species

Unspecified reactive species

Ning-Ning Dang,Xiao-Bing Li,Mei Zhang,Chen Han,Xiao-Yong Fan,Shu-Hong Huang

International journal of molecular medicine 46:1409-1422 PubMed32945349

2020

Overexpression of FcγRIIB regulates downstream protein phosphorylation and suppresses B cell activation to ameliorate systemic lupus erythematosus.

Applications

Unspecified application

Species

Unspecified reactive species

Linlin Sheng,Xiuqin Cao,Shuhong Chi,Jing Wu,Huihui Xing,Huiyu Liu,Zhiwei Yang

eLife 8: PubMed31282857

2019

Unique-region phosphorylation targets LynA for rapid degradation, tuning its expression and signaling in myeloid cells.

Applications

Unspecified application

Species

Unspecified reactive species

Ben F Brian,Adrienne S Jolicoeur,Candace R Guerrero,Myra G Nunez,Zoi E Sychev,Siv A Hegre,Pål Sætrom,Nagy Habib,Justin M Drake,Kathryn L Schwertfeger,Tanya S Freedman

Biochimica et biophysica acta. Molecular cell research 1866:1498-1507 PubMed31255720

2019

Estrogen enhances human osteoblast survival and function via promotion of autophagy.

Applications

Unspecified application

Species

Unspecified reactive species

Shubhangi Gavali,Manoj Kumar Gupta,Bhavna Daswani,Mohan R Wani,Ravi Sirdeshmukh,M Ikram Khatkhatay

Cell reports 25:3674-3692.e10 PubMed30590041

2018

Dual Mechanisms of LYN Kinase Dysregulation Drive Aggressive Behavior in Breast Cancer Cells.

Applications

Unspecified application

Species

Unspecified reactive species

Giusy Tornillo,Catherine Knowlson,Howard Kendrick,Joe Cooke,Hasan Mirza,Iskander Aurrekoetxea-Rodríguez,Maria D M Vivanco,Niamh E Buckley,Anita Grigoriadis,Matthew J Smalley

Biochimica et biophysica acta. Molecular basis of 1865:547-557 PubMed30579930

2018

LYN, a key mediator in estrogen-dependent suppression of osteoclast differentiation, survival, and function.

Applications

Unspecified application

Species

Unspecified reactive species

Shubhangi Gavali,Manoj Kumar Gupta,Bhavna Daswani,Mohan R Wani,Ravi Sirdeshmukh,M Ikram Khatkhatay
View all publications

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com